|
Antibodies in banana roots kill vermin
FreshPlaza An international team of researchers around Dirk Hölscher of the Max Planck Institute for chemical ecology in Jena, has discovered that some banana plants can accumulate antibodies against the thread worm, Radopholus similis, purposefully in their … |
Postmenopausal women: higher mortality linked to RA, antibodiesMedical News TodayMortality rates are two times higher in postmenopausal women with rheumatoid arthritis and anti-cyclic citrullinated peptide antibodies, researchers from the University of…
Monoclonal Antibody Industry for Global & China Markets Forecasts to 2017 in …DigitalJournal.comIn 2012, the global best-selling Infliximab (Johnson & Johnson), Etanercept (Amgen), Bevacizumab (Roche), Rituximab (Roche), Adalimumab (AbbVie) a…
Teva Announces Additional Regulatory Exclusivity for TREANDA …Lifescience-onlineTREANDA is indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with ritux…
Global and China Monoclonal Antibody Industry Report, 2013 – 2017SBWire (press release)In 2012, the global best-selling Infliximab (Johnson & Johnson), Etanercept (Amgen), Bevacizumab (Roche), Rituximab (Roche), Adalimumab (AbbVie) and Trastuzumab …
Global and China Monoclonal Antibody Industry with 2017 ForecastsThe International News MagazineIn 2012, the global best-selling Infliximab (Johnson & Johnson), Etanercept (Amgen), Bevacizumab (Roche), Rituximab (Roche), Adalimumab (AbbVie) and Tra…
|
RA Antibodies Tied to Higher Mortality Risk
MedPage Today Postmenopausal women with rheumatoid arthritis (RA) who had highly RA-specific antibodies had twice the mortality rate of healthy women, analysis of data from the Women’s Health Initiative found. All-cause 10-year mortality among women who tested … Higher mortality in postmenopausal women with RA and anti-CCP antibodiesEurekAlert (press release) |
Surgical Infection Rate Higher with RA DrugsArthritis Today… hydroxychloroquine (Plaquenil), azathioprine (Azasan, Imuran), cyclosporine (Neoral, Gengraf) and gold (Aurofin); TNF inhibitors, including etanercept (Enbrel), adalimumab (Humira) and infl…
|
Cancer Immunotherapy: A breakthrough made through animal research
Speaking of Research For, example back in 2009 Emma Stokes wrote an article for this blog on the discovery and development of Rituximab, a chimeric antibody therapy that has revolutionized the treatment of B-cell cancers such as Non-Hodgkin’s lymphoma. This work has not … |
Clinical Oncology News |
Bruce Cheson, MD: How I Treat Follicular Lymphoma—Part II
Clinical Oncology News The role for maintenance rituximab or consolidation radioimmunotherapy remains controversial, as neither prolongs overall survival (OS). New therapies that target the cell surface, pathways downstream from the B-cell receptor, apoptotic pathways and … |